Gates, others launch US$500m maternal, newborn health fund, bucking aid cuts trend
The Beginnings Fund was launched today in Abu Dhabi, the home of another key backer - the United Arab Emirates' recently established Mohamed Bin Zayed Foundation for Humanity.
The project has been in the works for at least a year. But its role has become more important as governments worldwide follow the US in pulling back from international aid, its chief executive Alice Kang'ethe told Reuters in an interview.
'It is an opportune moment,' she said earlier this month, stressing that the fund aimed to work alongside African governments, experts and organisations rather than parachuting in experts or technologies, an approach she said differed from many traditional donor programmes.
'Two generations ago... women in the UAE used to die during childbirth. More than half of children did not survive past childhood,' said Tala Al Ramahi at the Mohamed Bin Fayed Foundation, saying the lessons learned in what worked to change those outcomes would help inform the effort.
The Beginnings Fund aims to save the lives of 300,000 mothers and newborn babies by 2030, and expand quality care for 34 million mothers and babies.
The partners also pledged US$100 million in direct investments in maternal and child health, separate to the fund.
It plans to operate in Ethiopia, Ghana, Kenya, Malawi, Lesotho, Nigeria, Rwanda, Tanzania, Uganda, and Zimbabwe, focusing on low-cost interventions and personnel in high-burden hospitals. The work will track and target the key reasons babies and mothers die, including infection, severe bleeding for mothers, and respiratory distress for infants.
The world has made major progress in reducing newborn and maternal deaths, halving the neonatal mortality rate between 1990 and 2022. But that progress has stagnated or even reversed in nearly all regions in the last few years, according to the World Health Organisation, which has warned that aid cuts could make this worse.
'Mothers and newborns should not be dying from causes we know how to prevent,' said Dr. Mekdes Daba, minister of health for Ethiopia, stressing that the majority of deaths are avoidable.
Kang'ethe said the Beginnings Fund, like other philanthropies, was getting calls to fill gaps in global aid funding, but remained focused on its long-term aim of changing the trajectory of mother and newborn survival.
The fund is also backed by the Children's Investment Fund Foundation, Delta Philanthropies and the ELMA Foundation, among others. It will be led from Nairobi, Kenya. — Reuters
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
2 days ago
- Free Malaysia Today
Health ministry drops case against doctor for dispensing ivermectin
Health ministry officials had seized the antiparasitic drug found in Dr Che Amir Farid Che Isahak's clinic, arguing that it was not a registered product. (Reuters pic) PETALING JAYA : The health ministry has withdrawn a criminal case against a doctor for possessing and dispensing ivermectin. Dr Che Amir Farid Che Isahak said the ministry's decision to drop the case yesterday followed a ruling made by the Federal Court four months ago on a related matter. In March, the apex court unanimously decided to uphold doctors' right to give patients ivermectin. Health ministry officials had raided Che Amir's clinic in Ampang in 2021 during the peak of the Covid-19 pandemic. The raid followed reports that two patients, unconnected to Che Amir, had self-prescribed ivermectin and allegedly suffered acute poisoning and breathing difficulties. Officials seized the antiparasitic drug found in the clinic, arguing that it was not a registered product. They also claimed that the doctor was not legally permitted to sell or dispense the drug. Che Amir was subsequently charged in the magistrates' court with selling and dispensing the drug. When contacted, Che Amir said although the case resulted from the use of ivermectin for Covid-19 patients, the court's decision allows doctors who are proponents of the drug to use it for the prevention or treatment of any other types of diseases or conditions. 'And we can now safely prescribe and dispense ivermectin without fear of being raided anymore.' He also said more diseases had been found to be amenable to treatment with ivermectin, including cancer. However, he said while there had been many preclinical studies, no clinical study had been conducted. 'Ivermectin is emerging as a treatment for many types of cancer. 'For now there are only case reports and testimonies on the treatment of cancer with ivermectin. I hope that clinical trials will be conducted soon.'
The Star
3 days ago
- The Star
Explainer-What is CTE and its connection to the NFL and other contact sports?
FILE PHOTO: Oversized football helmets surround the convention center as the city hosts Super Bowl LIIV in Miami, Florida, U.S., January 31, 2020. REUTERS/Mike Blake/File Photo NEW YORK (Reuters) -A gunman who opened fire in a Midtown Manhattan office building on Monday believed he suffered a brain injury that he blamed on the National Football League, New York's mayor said, thrusting the issue of chronic traumatic encephalopathy back into headlines this week. According to police, Shane Tamura, a 27-year-old former high school football player with a history of mental illness, killed four people with an assault rifle in a Park Avenue office tower that houses NFL headquarters before shooting himself in the chest. The following is a breakdown of what CTE is and its relationship to contact sports. WHAT IS CTE? CTE is a degenerative disease caused by repeated impacts to the head, including both concussive and asymptomatic non-concussive hits. Doctors are only able to make a confirmed diagnosis after death, though common symptoms including aggression and dementia may surface while a patient is living. WHAT IS THE RELATIONSHIP BETWEEN THE NFL AND CTE? Research has found a connection between CTE and athletes who have competed in tackle football at both the professional and amateur levels. The NFL has acknowledged a link between football-related concussions and CTE. In 2015, the league agreed to a roughly $1-billion settlement for concussion-related lawsuits with thousands of retired players after the deaths of some high-profile players. Boston University's CTE Center diagnosed 345 former NFL players with CTE out of 376 studied, as of 2023. "If they've been exposed to football for a long time, that increases their risk," Dr. Ann McKee, director of the CTE Center, told Reuters. DID TAMURA PLAY IN THE NFL? Tamura did not compete in the NFL, the highest level of professional American football, but played at a Los Angeles charter school until graduating in 2016. WHAT ARE SOME EXAMPLES OF CTE AMONG FORMER PLAYERS? Junior Seau, a 12-time Pro Bowl linebacker and Hall of Famer, died by suicide in 2012. A study of his brain later showed he had suffered from CTE, a case that accelerated the national conversation around brain injuries in the NFL. Former New England Patriots player Aaron Hernandez, who was found guilty of first-degree murder in 2015 and died by suicide in prison in 2017, was found to have pronounced signs of the disease, according to Boston University findings. Ex-NFL player Phillip Adams gunned down six people and himself in 2021. McKee found he had suffered Stage 2 CTE after examining his brain. WHAT HAS THE NFL DONE TO MITIGATE BRAIN INJURIES? Concussions fell to a record low during the most recent NFL season, with the league crediting improvements in helmet technology as well as rule changes for the decline. Enhanced concussion protocols were implemented in 2022 after the NFL faced intense criticism over head injuries suffered by Miami Dolphins quarterback Tua Tagovailoa. The league previously banned dangerous helmet-to-helmet hits. But some researchers, including McKee, have said the measures fall short. "They have addressed concussion, but that's the tip of the iceberg. The real issue is the asymptomatic hits to the head that don't cause concussion, and there's been very little done to address that," said McKee. WHAT ABOUT OTHER SPORTS? Researchers have identified a connection between CTE and other sports, including rugby, ice hockey, and soccer. A group action in the United Kingdom involves more than 1,000 mostly former rugby players, including many high-profile internationals, who say the sport's governing bodies failed to do enough to protect them from potential brain injuries despite being aware of the risks. World Rugby, the sport's governing body, has introduced a series of player welfare measures in recent years in an attempt to minimize concussions and head injuriesin the sport. (Reporting by Amy Tennery in New York, additional reporting by Thomas Rowe and Mitch Phillips; Editing by Frank McGurty and Rod Nickel)
Malay Mail
4 days ago
- Malay Mail
AstraZeneca beats Q2 forecasts on booming US drug sales, eyes US$80b revenue by 2030
LONDON, July 29 — AstraZeneca Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney disease medicines and strong demand in the US, where it has invested US$50 billion (RM212 billion) to expand amid tariff threats from Washington. The performance is a boost for the UK's largest-listed company by market value as the wider sector braces for US tariffs on pharmaceutical imports and navigates pressure after President Donald Trump's order pushing for drugmakers to cut US prices to what other countries pay. AstraZeneca shares rose as much as 2.2 per cent by 0813 GMT. The drugmaker in April forecast only a limited impact from potential US tariffs, adding it would be able to meet its annual outlook if the levies on European imports were similar to those in other industries. A European Union-US trade deal over the weekend will result in a 15 per cent tariff on pharmaceuticals from the region. The US accounted for more than 40 per cent of AstraZeneca's revenue in 2024. The company had prioritised the market — the world's largest, worth US$635 billion — even before Trump's return to office. AstraZeneca is betting on a wave of expected launches of 20 new medicines and its US expansion to reach US$80 billion in annual revenue by 2030 and offset generic competition. On Tuesday, it maintained its 2025 outlook and increased its interim dividend by 3 per cent. 'Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent,' CEO Pascal Soriot said. Cancer drugs outperform Sales of oncology drugs, constituting nearly half of AstraZeneca's revenue, were up 18 per cent at US$6.31 billion at constant currency rates in the quarter. Jefferies analysts said sales of drugs including Tagrisso, Lynparza, Calquence, Truqap and Imfinzi beat expectations. Total revenue for the three months ended June grew 11 per cent to US$14.46 billion, with double-digit growth in the US despite headwinds from changes in US Medicare price negotiations. Core earnings stood at US$2.17 per share. That compares with analysts' expectations of US$2.16, and US$14.15 billion in sales, according to a company-provided consensus. 'Operationally, this is the type of quarter we want to see,' Barclays analysts said. AstraZeneca is also hoping to move on from scandals in its second-biggest market, China, where it this year faced minor fines related to cancer drugs. It is also fighting patent challenges from an individual against Tagrisso. The company also delayed late-stage Avanzar trial data for a key lung cancer treatment to the first half of 2026. — Reuters
